General Information about the Masimo softFlow

Method & effect

With softFlow therapy, a constant, warm and moist air flow, combined with oxygen if necessary, is applied to the patient’s nose through a thin nasal cannula (applicator). This generally leads to an improvement in ventilation. Therapy with softFlow shows a high level of therapy acceptance with excellent therapeutic success. There is currently a range of evidence and clinical findings that therapy with softFlow actually:

• supports insufficient breathing and shows clinical benefits
• brings improved elimination of CO2
• promotes a reduction in functional dead space
• supports and relieves the respiratory muscle pump
• can be an alternative to NIV in hypercapnic COPD patients

The findings presented recommend softFlow therapy in particular as a possible therapy option for further reducing mechanical respiratory support or for patients who cannot tolerate conventional mask ventilation. The precision of the flow, even with the smallest flow volumes, means that it can be used safely even with our youngest patients.

Benefits of softFlow therapy

• from clinic to home care with just one device
• precise flow regulation even at smallest flow rates
• continuous adjustment of the flow rate
• therapy without side effects
• no interruption of therapy when eating/drinking or medication intake necessary
• high therapy acceptance due to comfortable, mask-free therapy
• bacterial filter between device and patient reduces the risk of cross-contamination
• cost-efficient, quick change between patients possible
• variable use from premature babies to adults
• mobile application for up to 60 minutes thanks to portable battery
• condensate-free thanks to heated applicator from the device to the nasal cannula
• stable, precise flow during inspiration and expiration

References for the application of softFlow

Universitätsklinikum Würzburg

Josef-Schneider-Str. 2

97080 Würzburg